Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Primary Immune Thrombocytopenia (ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Large-scale testing (Phase 3)Study completedNCT01438840
What this trial is testing

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Who this might be right for
Chronic ThrombocytopeniaImmune Thrombocytopenia
Eisai Inc. 49
Not applicableLooking for participantsNCT06817395
What this trial is testing

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Massachusetts General Hospital 100
Post-approval studies (Phase 4)Study completedNCT03119974
What this trial is testing

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

Who this might be right for
Persistent or Chronic ITP
Assistance Publique - Hôpitaux de Paris 48
Large-scale testing (Phase 3)Looking for participantsNCT07194850
What this trial is testing

Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITP - Immune ThrombocytopeniaITP+4 more
argenx 24
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Large-scale testing (Phase 3)Looking for participantsNCT06722235
What this trial is testing

Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Takeda 171
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Large-scale testing (Phase 3)UnknownNCT03177629
What this trial is testing

H. Pylori Eradication for Moderate ITP

Who this might be right for
Immune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia
Seoul National University Hospital 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603557
What this trial is testing

Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Who this might be right for
Chronic Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 52
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Post-approval studies (Phase 4)UnknownNCT03172676
What this trial is testing

Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Assiut University 75
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Post-approval studies (Phase 4)Study completedNCT03229746
What this trial is testing

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assiut University 40
Post-approval studies (Phase 4)Ended earlyNCT03866798
What this trial is testing

Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Immune Thrombocytopenia
Octapharma 6
Not applicableStudy completedNCT01668615
What this trial is testing

Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Post-approval studies (Phase 4)UnknownNCT03201848
What this trial is testing

The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Qidong Gaitianli Medicines Co., Ltd 216
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Early research (Phase 1)Study completedNCT03275454
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Bioverativ, a Sanofi company 12
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Next Page